Virtual monoenergetic dual-energy computed tomography: optimization of kiloelectron volt settings in head and neck cancer.

OBJECTIVES: The aim of this study was to evaluate the effects on objective and subjective image quality of virtual monoenergetic reconstructions at various energy levels of dual-energy computed tomography (DECT) in patients with head and neck cancer. MATERIALS AND METHODS: We included 71 (53 men, 18 women; age, 59.3 ± 12.0 years; range, 33-90 years) patients with biopsy-proven untreated primary (n = 55) or recurrent (n = 16) squamous cell carcinoma who underwent head and neck DECT. Images were reconstructed with a linear blending setting emulating 120 kV acquisition (M_0.3; 30% of 80 kV, 70% of 140 kV spectrum) and as virtual monoenergetic images with photon energies of 40, 60, 80, and 100 keV. Attenuation of lesion, various anatomic landmarks, and image noise were objectively measured, and lesion contrast-to-noise ratio (CNR) was calculated. Two independent blinded radiologists subjectively rated each image series using a 5-point grading scale regarding overall image quality, lesion delineation, image sharpness, and image noise. RESULTS: Tumor attenuation peaked at 40 keV (140.2 ± 42.6 HU) followed by the 60 keV (121.7 ± 25.5 HU) and M_0.3 series (102.7 ± 22.3; all P < 0.001). However, the calculated lesion CNR was highest in the 60 keV reconstructions (12.45 ± 7.17), 80 keV reconstructions (8.66 ± 6.58), and M_0.3 series (5.21 ± 3.15; all P < 0.001) and superior to the other monoenergetic series (all P < 0.001). Subjective image analysis was highest for the 60 keV series regarding overall image quality (4.22; κ = 0.411) and lesion delineation (4.35; κ = 0.459) followed by the M_0.3 series (3.81; κ = 0.394; 3.77; κ = 0.451; all P < 0.001). Image sharpness showed no significant difference between both series (3.81 vs 3.79; P = 0.78). Image noise was rated superior in the 80 and 100 keV series (4.31 vs 4.34; P = 0.522). CONCLUSIONS: Compared with linearly blended images, virtual monoenergetic reconstructions of DECT data at 60 keV significantly improve lesion enhancement and CNR, subjective overall image quality, and tumor delineation of head and neck squamous cell carcinoma.

Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.

Inhibition of the polo-like-kinase-1 (PLK-1) has been shown to be effective in several haematological and solid tumor models. In this systemic in vitro study, the antitumor effect of BI2536, a small molecule inhibitor of PLK-1, in combination with cisplatin and docetaxel was examined in nine squamous cell carcinoma cell lines, most of which had a head and neck origin (SCCHN). Dose escalation studies were conducted with nine SCCHN cell lines using BI2536, cisplatin and docetaxel in cell line-specific concentrations. Growth inhibitory and proapoptotic effects were measured quantitatively using cytohistology and a Human Apoptose Array kit. BI2536 in combination with cisplatin and docetaxel showed a markedly higher antiproliferative and apoptotic activity in the SCCHN cell lines investigated (P≤0.008), compared with single agent cisplatin or docetaxel alone. The findings of this study showed that the addition of PLK-1-inhibitor BI2536 to conventional chemotherapeutic drugs led to a statistically higher antiproliferative and apoptotic effect in SCCHN cell lines compared with cisplatin or docetaxel alone. Inaugurating BI2536 in the clinical setting might enhance the antitumoral activity of conventional drugs, possibly leading to less toxic side effects of cancer therapy.

The role of recombinant epidermal growth factor and serotonin in the stimulation of tumor growth in a SCCHN xenograft model.

One challenge of squamous cell carcinoma of the head and neck (SCCHN) chemotherapy is a small percentage of tumor cells that arrest in the G0 phase of the cell cycle and are thus not affected by chemotherapy. This could be one reason for tumor recurrence at a later date. The recruitment of these G0-arresting cells into the active cell cycle and thus, proliferation, may increase the efficacy of chemotherapeutic agents. The aim of this study was to investigate whether stimulation with recombinant epidermal growth factor (EGF) or serotonin leads to an increased tumor cell proliferation in xenografts. Detroit 562 cells were injected into NMRI-Foxn1nu mice. Treatment was performed with 15 µg murine or human EGF, or 200 µg serotonin. The control mice were treated with Lactated Ringer's solution (5 mice/group). Tumor size was measured on days 4, 8 and 12 after tumor cell injection. The EGF stimulated mice showed a significantly higher tumor growth compared to the serotonin-stimulated mice and the untreated controls. In the present study, we show that it is possible to stimulate tumor cells in xenografts by EGF and thus, enhance cell proliferation, resulting in a higher tumor growth compared to the untreated control group. In our future investigations, we plan to include a higher number of mice, an adjustment of the EGF dosage and cell subanalysis, considering the heterogeneity of SCCHN tumors.

Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.

AIM: There is no common standard defining how biopsies for translational research purposes should be performed. In our study, the impact of two different biopsy methods on the results of immunohistochemical staining of the samples for epidermal growth factor receptor (EGFR) and the proliferation antigen Ki-67 were evaluated. PATIENTS AND METHODS: Twenty-four patients who underwent surgical treatment of their HNSCC tumour were included. From each surgically resected tumour, one superficial biopsy and one core-needle biopsy through the cross-section of the tumour were taken. As a positive control, a tissue slide through the primary tumour was made. RESULTS: The analysis showed that neither the superficial nor the core biopsy expression of EGFR correlated significantly with that of the tumour. The analysis showed that the superficial biopsy expression of Ki-67 correlated significantly with that of tumour. CONCLUSION: Translational research projects based on biopsy tissues should be using whole surgical resection specimens of a tumour.

The metabolic signature related to high plant growth rate in Arabidopsis thaliana.

The decline of available fossil fuel reserves has triggered world-wide efforts to develop alternative energy sources based on plant biomass. Detailed knowledge of the relations of metabolism and biomass accumulation can be expected to yield powerful novel tools to accelerate and enhance energy plant breeding programs. We used metabolic profiling in the model Arabidopsis to study the relation between biomass and metabolic composition using a recombinant inbred line (RIL) population. A highly significant canonical correlation (0.73) was observed, revealing a close link between biomass and a specific combination of metabolites. Dividing the entire data set into training and test sets resulted in a median correlation between predicted and true biomass of 0.58. The demonstrated high predictive power of metabolic composition for biomass features this composite measure as an excellent biomarker and opens new opportunities to enhance plant breeding specifically in the context of renewable resources.